Clinical trial
Angiotensin 2 Receptor (AT2R) Expression/Activation in Endothelial Cells in Preeclampsia
NCT03806283 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Angiotensin 2 Receptor (AT2R) Expression/Activation in Endothelial Cells in Preeclampsia
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 20, 2018
- Completion date
- April 30, 2027
- Enrollment
- 166 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.